Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain containing 12 pseudogene 6 (THAP12P6) is a human pseudogene. It is annotated as a non-protein-coding genomic element related to the functional gene THAP12, which encodes a zinc-dependent DNA-binding protein involved in transcriptional regulation and other cellular processes. As a pseudogene, THAP12P6 lacks evidence of protein expression or biological function and is not considered a therapeutic target or biomarker[1]. THAP12P6 is a non-functional pseudogene and not a receptor, enzyme, or other pharmacologically relevant protein target. No biological, pharmacological, or clinical information is attributed to it as a target[1]. Information about THAP domain protein family functions, disease roles, and interactors pertains to distinct protein-coding genes rather than this pseudogene[2][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain containing 12 pseudogene 6 (THAP12P6).